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Abstract
About 30–40% of male infertility is due to unknown reasons. Genetic contributions to the
disruption of spermatogenesis are suggested and amongst the genetic factors studied, Y
chromosome microdeletions represent the most common one. Screening for microdeletions in
AZFa, b and c region of Y chromosome showed a big variation among different studies. The
purpose of this study was to investigate the prevalence of such deletions in Saudi men. A total of
257 patients with idiopathic oligo- or azoospermia were screened for Y chromosome
microdeletions by 19 markers in AZF region. Ten (3.9%) patients had chromosomal
rearrangements, six of them showed sex chromosome abnormalities and four patients had
apparently balanced autosomal rearrengements. Eight of the remaining 247 patients (3.2%) with a
normal karyotype and no known causes of impaired spermatogenesis had Y chromosome
microdeletions. Among these, six patients had deletions in AZFc region, one case had a deletion in
AZFb and another had both AZFa and AZFc deletions.
In conclusion, our study shows that Y chromosome microdeletions are low in our population. We
also report for the first time a case with unique point deletions of AZFa and AZFc regions. The
lower frequency of deletions in our study suggest that other genetic, epigenetic, nutritional and
local factors may be responsible for idiopathic oligo- or azoospermia in the Saudi population.
Introduction
Approximately 10–15% of couples are affected by infertil-
ity. A male factor can be diagnosed in approximately 50%
of them and about 30–40% of male infertility is due to
unknown origin [1]. Little is known about the genetic dis-
orders that cause disruption of spermatogenesis. Early
cytogenetic studies showed that microscopic deletions in
the long arm of Y chromosome are responsible for
azoospermia [2]. With the advancement in molecular
biology, three non-overlapping regions named "azoosper-
mia factors" (AZFa, b, c from proximal to distal Yq region)
have been defined as spermatogenesis loci [3]. It is now
widely accepted that deletions within those three regions
severely diminish the sperm production [4]. The power of
polymerase chain reaction (PCR) and the availability of
sequence-tagged site (STS) maps made possible the detec-
tion of interstitial deletions in Yq11 region that was invis-
ible by karyotyping [5]. Such microdeletions have been
reported with varied prevalence in different populations
and studies [6].
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Table 1: Cytogenetic abnormalities observed in infertile men with their semen analysis and Y chromosome microdeletion status. (NA-not applicable; NP-not performed)
Patients 064 0118 0139 0180 0211 0219 0185 0156 0295 0199
Karyotyping 46,XY,inv(1) (q12 
or q21q42)
46,X,inv(Y) 
(p11.3q11.2)
47,XYY 47,XXY 47,XXY 47,XXY 45,X/46,XX 
mosaicism
46,X, t(X;Y) 
(p22.3;p11.2)
45,XY, 
der(13;14) 
(q10;q10)
46,XY, t(1,12) 
(q25;q24.3)
Y chromosome 
microdeletion
None None None None None None SY160 in AZFc All deleted None None
Semen analysis Severe 
oligozoospermia
Azoospermia Severe 
oligozoospermia
Azoospermia Azoospermia Azoospermia Severe 
oligozoospermia
Azoospermia oligozoospermia Severe 
oligozoospermia
Testicular biopsy 
(wet 
preparation)
NA No sperm seen NA NP Sperm found No sperm seen NA NP NA NA
Testicular 
Volume: left
right
12
12
15
15
15
20
3
3
6
6
12
12
15
18
8
10
NP 12
12
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The introduction of intracytoplasmic sperm injection
(ICSI) into the treatment of male factor infertility [7] per-
mitted the use of sperm from oligo- or azoospermic
patients to achieve successful fertilization and pregnan-
cies. This technology raised both hopes for infertile men
to have their own child, which would be otherwise impos-
sible and concerns to medical professionals about inherit-
ance of Y chromosome deletions and genetic disorders to
the next generations. Although these patients have a right
to father a child with the current technology, however,
they should be counseled about the risk they are transmit-
ting to their offspring [8]. The aim of this study was to
screen for Y chromosome microdeletions in infertile
males who were candidate for ICSI treatment and with idi-
opathic oligo- or azoospermia.
Materials and methods
Patients
A total of 257 Saudi infertile patients with idiopathic oli-
gozoospermia or azoospermia were enrolled in the study.
Patients were recruited from the infertility clinic in King
Faisal Specialist Hospital and Research Center. All males
were subjected to complete physical exam, semen analysis
and endocrine work-up (FSH, LH, TSH, testosterone, pro-
lactin). Patients with two consecutive specimens with
sperm count less than 10 × 106/ml were marked as candi-
date for the study and referred to an andrologist. These
candidates were checked for the history of relevant medi-
cal disorders e.g. diabetes, sickle cell disease, liver and
renal disease, radiation, endocrine abnormality (e.g. pro-
lactinoma, hypogonadotropic hypogonadism); exposure
to toxins and/or medication affecting spermatogenesis;
gross dismorphic abnormalities; acquired and congenital
structural defects of urogenital system (cystic fibrosis,
Young syndrome); history of surgical intervention of gen-
ital tract obstruction/dysfunction. Patients with positive
evidence of any of the above conditions were excluded
from the study. Upon diagnosing idiopathic oligo- or
azoospermia, patients were counseled for the study and
asked to sign an informed consent form for karyotyping
and Y chromosome microdeletion analysis. DNA isolated
from 53 Saudi men with normal semen analysis was used
as controls. An IRB approval was obtained for the study.
Karyotyping
Cytogenetic analysis was performed from phyto-haemag-
glutinin stimulated lymphocyte cultures by routine labo-
ratory protocol. For microscopic analysis, metaphase
chromosomes were stained with trypsin-Giemsa tech-
nique [9]. For chromosome analysis, 10 to 20 cells were
analyzed; and two to five metaphases were karyotyped.
For the definition of chromosomal abnormalities, Inter-
national System for Human Cytogenetic Nomenclature
(ISCN) was followed [10].
DNA extraction and PCR
Genomic DNA was prepared from peripheral blood sam-
ples using DNAzol according to the manufacturer instruc-
tions (InVitrogen, USA). A total of 19 specific targeted
sequences (STSs-3 markers in AZFa, 7 markers in AZFb
and 9 markers in AZFc) have been assessed using
polymerase chain reaction (PCR) (Table 1). Polymerase
Table 2: Schematic overview of the Yq11 microdeletions detected in 8 patients with unexplained oligo- or azoospermia. Positions of 
sequence-tagged sites (STS) and their location in AZF are also shown. Negative signs (-) indicate deletion of a STS; positive signs (+) 
indicate presence of a marker. The results of semen analysis and wet preparation testicular biopsy sperm search are shown in the last 
two columns (NA-not applicable; NP-not performed).
M a r k e r s A Z F 12345678
1S Y 8 2 A ++++++++
2 S Y 8 4 +++++++-
3 S Y 8 7 ++++++++
4S Y 1 2 5 B ++++++-+
5 S Y 1 2 9 ++++++-+
6 S Y 1 3 2 ++++++-+
7 S Y 1 3 4 ++++++-+
8 S Y 1 3 6 ++++++-+
9 S Y 1 4 3 ++++++-+
1 0 S Y 1 3 0 ++++++-+
11 SY153 C +-----+ +
12 SY148 + - - - - - + +
13 SY277 + - - - - - + +
14 SY279 + - - - - - + +
15 SY254 + - - - - - + -
16 SY154 + - - - - - + +
1 7 S Y 1 5 7 ------+ +
18 SY158 + - - - + + + +
1 9 S Y 1 6 0 ++++++++
Semen analysis Severe 
oligozoospermia
Severe 
oligozoospermia
Azoospermia Azoospermia Severe 
oligozoospermia
Severe 
oligozoospermia
Azoospermia Severe 
oligozoospermia
Testicular biopsy NA NA No sperm No sperm NA NA NP NAJournal of Experimental & Clinical Assisted Reproduction 2006, 3:1 http://www.jexpclinassistreprod.com/content/3/1/1
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chain reaction was run to amplify each locus separately
without using multiplex PCR. Female DNA and water
were used as negative controls. PCR was carried out in a
total volume of 20 µl and the reaction mixture included
40 ng of each DNA sample, 1 × PCR buffer, 1.5 mmol/l
MgCl2, 200 µmol/l dNTP 1 µmol/l of each primer pair
and 1 U Taq DNA polymerase (InVitrogene, USA). The
reactions were carried out in a thermal cycler (MJ
Research, USA). After an initial denaturation step at 94°C
for 5 min, PCR amplification of 35 cycles were performed
as follows: 95°C for 1 min for denaturation, 55–62°C
ramping for 80 sec for primer annealing and 72°C for 60
sec for extension. The programs were followed by the final
extension step at 72°C for 7 min. The reaction products
were then analyzed by electrophoresis at 100 V on 2%
agarose gels (Sigma, USA). In case a deletion was
observed, a second run was performed in order to confirm
the deletion in the presence of a positive control for that
deletion.
Results
A total of 257 patients were studied. Of those, 113 were
azoospermic men. Among 144 oligozoospermic men,
110 were severe oligozoospermic (<1 × 106/ml) and
remaining 34 had a sperm count between 1 × 106 and 10
× 106/ml. Ten (3.9%) patients had chromosome rear-
rangements. The results of cytogenetic analysis in 10 infer-
tile men are shown in Table 1. Three cases showed 47,XXY
karyotype consistent with Klinefelter syndrome, one case
with 47,XYY, one case with 45,X/46,XX mosaicism, two
cases with pericentric inversions of chromosome 1 and Y,
one case of t(X;Y) involving the pseudo-autosomal region
and the SRY gene confirmed by molecular cytogenetic
techniques and two cases of apparently balanced recipro-
cal translocation involving autosomes. The two patients
who had 45,X/46,XX mosaicism and t(X;Y) also showed Y
chromosome microdeletions by PCR. Semen analysis in
the whole group with chromosome rearrangements
ranged from azoospermia to oligozoospermia. Three out
of 5 azoospermic men had testicular biopsy performed for
the identification of sperm in wet preparation, only one
was positive for the presence of sperm (Table 1).
Eight patients (3.2%) out of remaining 247 with normal
karyotypes and no known causes of impaired sperma-
togenesis had Y chromosome microdeletions. Six patients
had deletions in AZFc region, one had a deletion in AZFb
and the other had both AZFa and AZFc deletions (Table
2). There were large deletions in six patients covering
many STSs, among these, five were almost similar cover-
ing most of the AZFc region and one showed complete
absence of AZFb markers used in this study. Regarding the
small deletions, one STS in AZFa and one in AZFc region
were missing in a patient (Fig 1) while in another, only
one AZFc STS marker was deleted (Table 2). Fifty-three
DNA samples extracted from patients with normal sperm
count, motility and morphology showed absence of any
deletions using the same STS markers.
Discussion
Y chromosome microdeletions have been in the increas-
ing interests of clinicians and scientists after ICSI was
introduced to be the main treatment option for severe
male factor infertility. Earlier studies showed high inci-
dence of Y chromosome microdeletions in idiopathic
oligo- or azoospermia [11-13] which prompted many
researchers to screen their populations. The frequency of
deletions was reported to be in the range of 0.7–34.5 %
with an average of 8.2% [6]. The results shown in this
study (8 out of 247; 3.2%) is in the lower part of this
range. The wide range of the deletions in different publi-
cations was suggested to be due to the ethnic composition
of the study populations in various studies. [14,15]. In
addition, the inclusion criteria could have also played an
important role in this variable frequency of deletion. Fur-
thermore, different protocols and the number of markers
used in the studies might have further contributed to the
variation. Karyotyping was also performed and the preva-
lence of abnormality was estimated to be 3.96% (10/
257). This is slightly lower than other reports [16,17].
Of the 247 patients with normal karyptypes and no
known cause of infertility, 3/108 (2.8%) azoospermic and
5/139 (3.6%) of oligozoospermic had Y chromosome
microdeletions, respectively. Although the rate of deletion
was similar in these two groups in our study, Y chromo-
some microdeletions in azoospermic patients was found
to be approximately two-fold more than oligozoospermic
ones in earlier studies [6]. This discrepancy again could be
due to our patient population or the threshold of sperm
concentration included for Y chromosome microdeletion
analysis. Our inclusion criteria were less stringent since all
idiopathic cases with less than 10 × 106/ml sperm count
were included in the study. All the deletions observed
a gel electrophoresis showing coexistence of AZF a and c  point deletions in the patient 8 Figure 1
a gel electrophoresis showing coexistence of AZF a and c 
point deletions in the patient 8. in the previous and the fol-
lowing STSs of deleted region were run together with the 
deleted STSs. M: marker; C: positive control (normal male); 
F: female DNA. Note the absence of any amplifications in 
SY84 and SY254. They are similar to female profile.Journal of Experimental & Clinical Assisted Reproduction 2006, 3:1 http://www.jexpclinassistreprod.com/content/3/1/1
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were in the severe oligozoospermic patients (<1 × 106/ml,
5/106, 4.7%) while none of 33 patients with sperm count
between 1 and 10 × 106/ml had any deletions. Similarly,
none of the 53 normozoospermic men included as nor-
mal control had any deletions in our population. This
indicates that none of the observed deletions in our study
is due to polymorphisms. Furthermore, overall deletion
in fertile controls has been reported to be less than 0.5%
in previously published reports [6,18].
Five out of 8 patients with Y chromosome microdeletions
have almost the entire AZFc region deleted. The infertility
phenotype of patients with large AZFc deletions varied
from azoospermia (2 patients) to severe oligozoospermia
(3 patients). It has been shown that reduction of the
sperm number leading to azoospermia might be second-
ary to time dependent germ cell regression [3,19]. In this
report, however, we did not see any trend of phenotype
changes according to ages.
One of the patient was carrying a deletion of the entire
AZFb. This deletion is larger than the one published by
Ferlin et al. [20]. The patient with AZFb deletion showed
an azoospermic phenotype which is in accordance with
the suggestions stating that AZFb deletion has an adverse
prognosis for finding sperm in testicular biopsies [21,22].
One patient with severe oligozoospermia in this study
had deletions of 2 STSs (one AZFa and other AZFc). These
deletions are unique and to the best of our knowledge this
is the first report showing AZFa and AZFc point deletions
in the same individual. Repeated testing with different
controls consistently confirmed the deletions in this
patient. Although deletions occurring in AZFa are mostly
associated with Sertoli cell only syndrome [23], severe oli-
gozoospermia in our patient with AZFa and AZFc dele-
tions was not surprising because Kamp et al. [23] also
reported that only complete AZFa deletion is associated
with the absence of sperm whereas there have been cases
of sperm retrieval with partial AZFa deletions.
Most deletions are de novo in origin and the transmission
of these deletions to the male offspring is 100% [24-27].
The percentage of Y chromosome microdeletions is lower
in our population; however, the common use of ICSI for
severe male factor infertility necessitates a proper coun-
seling.
In conclusion, Y chromosome microdeletions and chro-
mosomal rearrengements are low in our population, con-
tributing to a small percent of idiopathic oligo- and
azoospermia. This warrants that other additional genetic,
epigenetic, nutritional and local factors to be investigated
in the etiology of idiopathic oligo- or azoospermia.
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